U.S. Markets closed

Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
9.07+0.31 (+3.54%)
At close: 4:00PM EDT
People also watch
EXELARQLCLDXRIGLARIA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue6/30/20166/30/20156/30/2014
Total Revenue137,87951,90942,078
Cost of Revenue23,16644,39245,965
Gross Profit114,7137,517-3,887
Operating Expenses
Research Development160,65554,44249,824
Selling General and Administrative36,26731,43321,907
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-82,2093,293-75,618
Income from Continuing Operations
Total Other Income/Expenses Net24397,97477
Earnings Before Interest and Taxes-81,96619,616-75,541
Interest Expense10,87410,2479,716
Income Before Tax-92,8409,369-85,257
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-92,8409,369-85,257
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-92,8409,369-85,257
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-92,8409,369-85,257